InspireMD: Funding, Investors & Team (Sep 2026)
InspireMD is a company that specializes in creating unique medical devices, specifically their own stent system technology called MGuard. Their focus is on developing products for use in interventional cardiology as well as other vascular procedures. The company's overall goal is to utilize their technology to improve upon current stenting processes, and to make their stents the industry standard by creating solutions for clinical issues such as embolic showers, restenosis, and late stent thrombosis. InspireMD plans to explore developing their technology for both bare metal and drug eluting stents in procedures involving arteries in the coronary, carotid, and peripheral areas.
InspireMD has raised $114M across 1 funding round on record, the most recent an undisclosed round of $114M announced in May 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
InspireMD Company Profile and Key Stats
Latest funding round on record: May 2023.
InspireMD Funding Rounds
InspireMD Founders and Leadership Team
No contact details are on record for this team yet.
InspireMD Funding Compared to Other Biotechnology Startups
InspireMD's latest round of $114M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InspireMD in Biotechnology and Tel Aviv
Companies Similar to InspireMD
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
InspireMD Funding FAQs
What does InspireMD do?
InspireMD is a company that specializes in creating unique medical devices, specifically their own stent system technology called MGuard. Their focus is on developing products for use in interventional cardiology as well as other vascular procedures. The company's overall goal is to utilize their technology to improve upon current stenting processes, and to make their stents the industry standard by creating solutions for clinical issues such as embolic showers, restenosis, and late stent thrombosis. InspireMD plans to explore developing their technology for both bare metal and drug eluting stents in procedures involving arteries in the coronary, carotid, and peripheral areas.
How much funding has InspireMD raised?
InspireMD has raised $114M across 1 round on record. The most recent is an undisclosed round of $114M announced in May 2023.
When did InspireMD last raise funding?
InspireMD's most recent funding round on record is an undisclosed round of $114M, announced in May 2023.
Who is the CEO of InspireMD?
Marvin Slosman is listed as CEO at InspireMD.
Where is InspireMD headquartered?
InspireMD is based in Tel Aviv, Israel.
How many employees does InspireMD have?
InspireMD is in the 51-100 employee band.
How does InspireMD's funding compare to other Biotechnology startups?
InspireMD's latest round of $114M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's InspireMD Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InspireMD is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.